DGX Quest Diagnostics, Inc.
Quest Diagnostics, Inc. (DGX) is expected to report earnings on October 22, 2026, before the market open. The consensus earnings estimate is $2.85 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.8% since its last earnings release on July 23, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Quest Diagnostics, Inc.
Quest Diagnostics Inc is the provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions.
Sector
Healthcare
Industry
Medical Labs & Research